Evaluation of clinical effects and plasma metabolomic profiles after the administration of grapiprant in dogs affected by osteoarthritis: a prospective, off–on–off, clinical study

Claudia Piemontese, Chiara Roberta Girelli, Marzia Stabile, Luca Lacitignola, Agata Fraccascia, Antonio Crovace, Francesco Paolo Fanizzi, Francesco Staffieri · 2026

Read Evaluation of clinical effects and plasma metabolomic profiles after the administration of grapiprant in dogs affected by osteoarthritis: a prospective, off–on–off, clinical study by Claudia Piemontese, Chiara Roberta Girelli, Marzia Stabile, Luca Lacitignola, Agata Fraccascia, Antonio Crovace, Francesco Paolo Fanizzi, Francesco Staffieri (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13312814.txt.

Description

Claudia Piemontese and co-authors test, in a 2026 study, the pain drug grapiprant in dogs with osteoarthritis, pairing clinical scores with blood metabolite profiling. Grapiprant blocks the EP4 prostaglandin receptor and promises a safer profile than standard anti-inflammatory drugs, but its real-world effect on canine joint pain and body chemistry had not been tracked together.

Thirty-six dogs with mild to moderate disease went through an off-on-off design: 30 days untreated, 60 days on grapiprant at 2 mg per kg, then 30 days off again. Owner surveys showed pain and disability scores improved during treatment and partly slipped back afterward, and walkway gait measures improved by day 60. Plasma chemistry separated clearly before and after treatment. The shifts read as lower inflammation and better energy metabolism, a first step toward blood markers of drug response.

Catalog record

CREATORClaudia Piemontese, Chiara Roberta Girelli, Marzia Stabile, Luca Lacitignola, Agata Fraccascia, Antonio Crovace, Francesco Paolo Fanizzi, Francesco Staffieri
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE40407
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13312814

Browse the full library · About the Tower of Babel